PHGUF

Quote

Short

News

Articles

Message Board

Pharming Group N.V. (OTCMKTS : PHGUF ) News

Pharming Group N.V. (OTCMKTS: PHGUF) News Releases

PHGUF News Releases

June 04, 2026 01:00:00 am

GlobeNewswire

Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS

May 22, 2026 03:30:00 pm

GlobeNewswire

European Commission grants marketing authorization to Pharming's Joenja® (leniolisib) - the first approved treatment for APDS in the European Union

May 07, 2026 12:41:18 pm

SeekingAlpha

Pharming Group N.V. (PHAR) Q1 2026 Earnings Call Transcript

May 07, 2026 01:05:00 am

GlobeNewswire

Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders

May 07, 2026 01:00:00 am

GlobeNewswire

Pharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026

March 27, 2026 02:00:00 am

GlobeNewswire

Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older

March 24, 2026 02:00:00 am

GlobeNewswire

Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older

March 12, 2026 03:13:00 pm

SeekingAlpha

Pharming outlines $405M-$425M 2026 revenue target as Joenja and RUCONEST drive growth

March 12, 2026 03:12:21 pm

SeekingAlpha

Pharming Group N.V. (PHAR) Q4 2025 Earnings Call Transcript

March 12, 2026 02:33:56 am

SeekingAlpha

Pharming beats top-line estimates; introduces FY26 outlook

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account